Defibrillator News and Research

Latest Defibrillator News and Research

Medtronic launches Every Patient First health equity initiative.

Medtronic, Inc. today introduced Every Patient First, a health equity initiative that, in partnership with health care providers, professional societies and patient advocacy groups, aims to reduce disparities in access to health care in the United States. The announcement was made at the 59th Annual Scientific Session of the American College of Cardiology in Atlanta.

17 Mar 2010

InnerPulse selects Dassault Systemes' Abaqus FEA software

Dassault Systèmes, a world leader in 3D and Product Lifecycle Management (PLM) solutions, today announced that InnerPulse, a medical device company pioneering a novel technology for those patients with cardiac rhythm disorders, has selected Abaqus finite element analysis (FEA) software from the SIMULIA to assist in development of their technology designed in SolidWorks CAD software.

16 Mar 2010

St. Jude Medical to exhibit cardiac clinical solution products portfolio at ACC 2010

St. Jude Medical, Inc. today announced it will display products and technologies from the company’s wide array of clinical solutions in the cardiology, cardiac surgery, atrial fibrillation and cardiac rhythm management markets at ACC 2010.

12 Mar 2010

FAA's Public Access Defibrillation Program: Emergency University and HeartSine Technologies support

The Federal Aviation Administration (FAA) has announced its selection of Emergency University and HeartSine Technologies to provide nationwide Automated External Defibrillators (AEDs) and program management for ERT members.

6 Mar 2010

Study on impact of bystander CPR on pediatric cardiac arrest

Bystanders who perform cardiopulmonary resuscitation (CPR) on a child with cardiac arrest increase the child's likelihood of survival, according to the largest pediatric study to date. The outcomes are similar for both chest compression alone (hands-only) CPR and CPR with chest compression and rescue breathing.

3 Mar 2010

Patients admitted to hospice care are rarely having their ICDs deactivated

Researchers from Mount Sinai School of Medicine have found that patients admitted to hospice care who have an implantable cardioverter defibrillator (ICD) are rarely having their ICDs deactivated and are receiving electrical shocks from these devices near the end of life. This first-of-its-kind study of hospice patients with ICDs is published in the March 2, 2010 issue of the Annals of Internal Medicine.

2 Mar 2010

Guidant conceals defibrillator safety problems from FDA, is charged with criminal violations

Medical device manufacturer Guidant LLC, a wholly-owned subsidiary of Boston Scientific Corporation, was charged today with criminal violations of the Federal Food, Drug, and Cosmetic Act related to safety problems with some of its implantable defibrillators. Guidant LLC formerly did business as Guidant Corporation. The Justice Department filed the criminal information today in connection with an agreement with Guidant to resolve the charges. A formal guilty plea agreement is expected to be filed with the court at a later date.

26 Feb 2010

Medtronic third-quarter revenues up by 10%

Medtronic, Inc. today reported financial results for the third quarter of fiscal year 2010, which ended January 29, 2010.

23 Feb 2010

Study proves accuracy of MTWA non-invasive test in identifying patients at risk of arrhythmic events and SCD

Cambridge Heart, Inc., today announced that results of a clinical study presented at the 29th Annual Scientific Meeting of the Belgian Society of Cardiology in Brussels, Belgium, reinforce the value of the Microvolt T-wave Alternans (MTWA) as an accurate non-invasive test to identify patients at risk of arrhythmic events and sudden cardiac death (SCD).

23 Feb 2010

Belgian Hospital completes certification training for SynCardia's Total Artificial Heart implant

On Feb. 25 & 26, the surgical team from Onze Lieve Vrouw (OLV) Hospital Aalst, led by surgeons Ivo Deblier, MD, and Karl Dossche, PhD, and accompanied by anesthesiologist Koen De Decker, MD, will become the first hospital in Belgium and the 50th hospital in the world to complete the first phase of certification training to implant the SynCardia temporary CardioWest™ Total Artificial Heart.

23 Feb 2010

Physio-Control restarts unrestricted global shipments of LIFEPAK defibrillators following FDA approval

Physio-Control Inc., a wholly-owned subsidiary of Medtronic, Inc., announced today it received notice from the U.S. Food and Drug Administration (FDA) that having successfully met requirements for improvements to the quality system, the company may resume unrestricted worldwide shipments of its external defibrillators.

20 Feb 2010

Spectranetics fourth-quarter revenues rise up 11%

Spectranetics Corporation today reported financial results for the quarter and full year ended December 31, 2009.

18 Feb 2010

Boston Scientific rebuts HeartRhythm's cardiac resynchronization therapy defibrillator implantation article

Boston Scientific Corporation today rebutted an article published in the journal HeartRhythm. The article reported a case summary of a patient who had been implanted subcutaneously with a Cognis cardiac resynchronization therapy defibrillator. The article suggested a weakened header bond was responsible for the abnormal sensing and pacing impedance experienced by the patient.

11 Feb 2010

Corporate sponsors to be recognized at ENA Leadership Conference

The Emergency Nurses Association (ENA) today announced the corporate sponsors for the ENA Leadership Conference to be held in Chicago, Illinois on February 17-21, 2010.

11 Feb 2010

Boston Scientific reports fourth quarter and full year 2009 results

Boston Scientific Corporation today announced financial results for the fourth quarter and full year ended December 31, 2009, as well as guidance for net sales and earnings per share (EPS) for the first quarter and full year 2010.

10 Feb 2010

Sorin Group announces first implant of FDA approved Paradym CRT Model 8750 defibrillator

Sorin Group, a global leader in the treatment of cardiovascular disease, announced today U.S. FDA approval and first implant of its next-generation of cardiac resynchronization therapy defibrillator (CRT-D), Paradym™ CRT Model 8750. Featuring a new, state-of-the-art battery technology, Paradym™ CRT delivers 37 Joules, the highest energy of any implantable cardiac defibrillator (ICD) currently available.

6 Feb 2010

St. Jude Medical receives European approval for Fortify ST ICD and Unify CRT-D defibrillators

St. Jude Medical, Inc. today announced European CE Mark approval and first implants of its Fortify™ and Fortify ST implantable cardioverter defibrillators (ICD) and Unify™ cardiac resynchronization therapy defibrillator (CRT-D). The devices will be fully launched in Europe later this spring, and U.S. versions of the Fortify ICD and Unify CRT-D are expected to be launched later this year. The reduced size of these new devices compared to those of previous generations creates the smallest available device footprint in the industry.

5 Feb 2010

LExICon study evaluating laser assisted lead removal using Spectranetics laser sheath published

Spectranetics Corporation today announced publication of the four-year, retrospective LExICon (Lead Extraction in Contemporary Settings) study in the February 9th issue of the Journal of American College of Cardiology.

3 Feb 2010

Simple genetic test can help in detecting heart abnormalities

Hypertrophic Cardiomyopathy (HCM) is a genetic disease that causes the heart muscle to become abnormally large. It often goes undetected and, as a result, HCM has the dubious distinction of being the leading cause of sudden death in children, young adults and athletes.

2 Feb 2010

ZOLL Medical's LifeVest Wearable Defibrillator named one of top five innovative medical devices of 2009

ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Medical Device Network has named the LifeVest® Wearable Defibrillator as one of the five most innovative and life-changing medical devices of 2009.

28 Jan 2010

Defibrillator News and Research

Latest Defibrillator News and Research

Medtronic launches Every Patient First health equity initiative.

InnerPulse selects Dassault Systemes' Abaqus FEA software

St. Jude Medical to exhibit cardiac clinical solution products portfolio at ACC 2010

FAA's Public Access Defibrillation Program: Emergency University and HeartSine Technologies support

Study on impact of bystander CPR on pediatric cardiac arrest

Patients admitted to hospice care are rarely having their ICDs deactivated

Guidant conceals defibrillator safety problems from FDA, is charged with criminal violations

Medtronic third-quarter revenues up by 10%

Study proves accuracy of MTWA non-invasive test in identifying patients at risk of arrhythmic events and SCD

Belgian Hospital completes certification training for SynCardia's Total Artificial Heart implant

Physio-Control restarts unrestricted global shipments of LIFEPAK defibrillators following FDA approval

Spectranetics fourth-quarter revenues rise up 11%

Boston Scientific rebuts HeartRhythm's cardiac resynchronization therapy defibrillator implantation article

Corporate sponsors to be recognized at ENA Leadership Conference

Boston Scientific reports fourth quarter and full year 2009 results

Sorin Group announces first implant of FDA approved Paradym CRT Model 8750 defibrillator

St. Jude Medical receives European approval for Fortify ST ICD and Unify CRT-D defibrillators

LExICon study evaluating laser assisted lead removal using Spectranetics laser sheath published

Simple genetic test can help in detecting heart abnormalities

ZOLL Medical's LifeVest Wearable Defibrillator named one of top five innovative medical devices of 2009

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Defibrillator News and Research

Latest Defibrillator News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in